Trehalose polyphleates participate in Mycobacterium abscessus fitness and pathogenesis
Open Access
- 11 December 2024
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 15 (12) , e0297024
Abstract
Mycobacteria produce a large repertoire of surface-exposed lipids with major biological functions. Among these lipids, trehalose polyphleates (TPPs) are instrumental in the infection of Mycobacterium abscessus by the therapeutic phage BPs. However, while the biosynthesis and transport of TPPs across the membrane by MmpL10 have been reported, the role of TPPs in host infection remains enigmatic. Here, we addressed whether the loss of TPPs influences interactions with macrophages and the virulence of M. abscessus . As anticipated, the deletion of mmpL10 in smooth (S) and rough (R) variants of M. abscessus abrogated TPP production, which was rescued upon gene complementation. Importantly, infection of human THP-1 cells with the mmpL10 mutants was associated with decreased intramacrophage survival and a reduced proportion of infected cells. The rough mmpL10 mutant showed an impaired capacity to block phagosomal acidification and was unable to co-localize with Galectin-3, a marker of phagosomal membrane damage. This suggests that TPPs participate, directly or indirectly, in phagolysosomal fusion and in phagosomal membrane damage to establish cytosolic communication. The TPP defect that affects the fitness and virulence of M. abscessus was further demonstrated in zebrafish embryos using a rough clinical strain resistant to phage BPs and harboring a frameshift mutation in mmpL10 . Infection with this strain was correlated with a slight decrease in embryo survival and a reduced bacterial burden as compared to the corresponding parental and complemented derivatives. Together, these results indicate that TPPs are important surface lipids contributing to the pathogenicity of M. abscessus . IMPORTANCE: Trehalose polyphleates (TPPs) are complex lipids associated with the mycobacterial cell surface and were identified 50 years ago. While the TPP biosynthetic pathway has been described recently, the role of these lipids in the biology of mycobacteria remains yet to be established. The wide distribution of TPPs across mycobacterial species suggests that they may exhibit important functions in these actinobacteria. Here, we demonstrate that Mycobacterium abscessus, an emerging multidrug-resistant pathogen that causes severe lung diseases in cystic fibrosis patients, requires TPPs for survival in macrophages and virulence in a zebrafish model of infection. These findings support the importance of this underexplored family of lipids in mycobacterial pathogenesis.Keywords
Funding Information
- French National Research Agency (ANR-21-CE44-0027-01)
- French National Research Agency (ANR-20-CE44-0019)
- Fondation pour la Recherche Médicale (EQU202103012588)
- HHS | National Institutes of Health (GM131729)
- Howard Hughes Medical Institute (GT2053)
This publication has 63 references indexed in Scilit:
- Modeling nontuberculous mycobacterial infections in zebrafishTrends in Microbiology, 2023
- Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessusCell Chemical Biology, 2022
- Synovial Fluid Mediated Aggregation of Clinical Strains of Four Enterobacterial Species2021
- A paucity of knowledge regarding nontuberculous mycobacterial lipids compared to the tubercle bacillusTuberculosis, 2019
- NTM drug discovery: status, gaps and the way forwardDrug Discovery Today, 2018
- Biofilm colonization of Mycobacterium abscessus : New threat in hospital-acquired surgical site infectionIndian Journal of Tuberculosis, 2017
- MmpL transporter-mediated export of cell-wall associated lipids and siderophores in mycobacteriaTuberculosis, 2016
- Monstrous Mycobacterial LipidsCell Chemical Biology, 2016
- Trehalose Polyphleates Are Produced by a Glycolipid Biosynthetic Pathway Conserved across Phylogenetically Distant MycobacteriaCell Chemical Biology, 2016
- New use of BCG for recombinant vaccinesNature, 1991